Bioventus annual operating expenses
2019
2020
2021
2022
2023
2024
2025
Bioventus Operating Expenses Growth & History (BVS)
Bioventus's operating expenses was $334.2M for fiscal 2025.
View full Bioventus company overviewBioventus annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $334.2M | −$69.2M | −17.16% |
| 2024 | 2024-12-31 | $403.4M | −$6.5M | −1.58% |
| 2023 | 2023-12-31 | $409.9M | −$88.4M | −17.74% |
| 2022 | 2022-12-31 | $498.3M | $207.7M | +71.45% |
| 2021 | 2021-12-31 | $290.6M | $78.4M | +36.91% |
| 2020 | 2020-12-31 | $212.3M | −$5.7M | −2.63% |
| 2019 | 2019-12-31 | $218.0M | — | — |
Bioventus quarterly operating expenses
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-27 | $86.5M | $2.8M | +3.36% |
| Q1 2026 | 2026-03-28 | $82.4M | $4.2M | +5.33% |
| Q4 2025 | 2025-12-31 | $89.3M | −$5.7M | −5.96% |
| Q3 2025 | 2025-09-27 | $83.0M | −$6.9M | −7.70% |
| Q2 2025 | 2025-06-28 | $83.7M | −$51.4M | −38.04% |
| Q1 2025 | 2025-03-29 | $78.2M | −$5.3M | −6.31% |
| Q4 2024 | 2024-12-31 | $95.0M | $9.8M | +11.53% |
| Q3 2024 | 2024-09-28 | $89.9M | $13.5M | +17.63% |
| Q2 2024 | 2024-06-29 | $135.1M | $52.7M | +64.02% |
| Q1 2024 | 2024-03-30 | $83.5M | −$82.5M | −49.72% |
| Q4 2023 | 2023-12-31 | $85.1M | −$4.7M | −5.22% |
| Q3 2023 | 2023-09-30 | $76.4M | −$134.9M | −63.84% |
| Q2 2023 | 2023-07-01 | $82.4M | −$17.6M | −17.60% |
| Q1 2023 | 2023-04-01 | $166.0M | $68.8M | +70.84% |
| Q4 2022 | 2022-12-31 | $89.8M | −$1.1M | −1.20% |
| Q3 2022 | 2022-10-01 | $211.4M | $131.3M | +163.83% |
| Q2 2022 | 2022-07-02 | $100.0M | $17.9M | +21.83% |
| Q1 2022 | 2022-04-02 | $97.2M | $59.6M | +158.67% |
| Q4 2021 | 2021-12-31 | $90.9M | $23.4M | +34.57% |
| Q3 2021 | 2021-10-02 | $80.1M | $24.6M | +44.27% |
| Q2 2021 | 2021-07-03 | $82.1M | $37.1M | +82.58% |
| Q1 2021 | 2021-04-03 | $37.6M | −$6.7M | −15.12% |
| Q4 2020 | 2020-12-31 | $67.6M | — | — |
| Q3 2020 | 2020-09-26 | $55.5M | — | — |
| Q2 2020 | 2020-06-27 | $44.9M | — | — |
| Q1 2020 | 2020-03-28 | $44.2M | — | — |
Bioventus operating expenses trends
Over the last five fiscal years, Bioventus's operating expenses increased from $212.3M to $334.2M, a change of $121.9M. The latest reported quarter, Q2 2026, shows $86.5M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Bioventus source filings ↗